"A multispecialty community hospital providing quality health care services to the residents of south central Connecticut."

During the past decade, Midstate Medical Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 20 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 19 clinical trials were completed. i.e. 211.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Midstate Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 12 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "NRG Oncology" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Midstate Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Midstate Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (4 trials), "Colorectal Cancer" (2 trials) and "Invasive Breast Carcinoma" (2 trials). Many other conditions were trialed in "Midstate Medical Center" in a lesser frequency.

Most popular intervention types in "Midstate Medical Center" are "Drug" (34 trials), "Other" (28 trials), "Biological" (15 trials), "Procedure" (9 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (12 trials), "Docetaxel" (8 trials), "Paclitaxel" (7 trials) and "Questionnaire Administration" (7 trials). Other intervention names were less common.

The vast majority of trials in "Midstate Medical Center" are 32 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Midstate Medical Center". undefined are not yet recruiting, 10 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Midstate Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Midstate Medical Center, 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".